In a prospective cohort study of over 800 patients, Zhou et al. demonstrated that elevated serum chemerin levels were predictive of major adverse cardiovascular events (MACEs) and independently associated with all-cause mortality in patients with chronic heart failure [163]. The gene discussed is RARRES2; the disease is congestive heart failure.